Detailed electrophysiologic testing, including microelectrode study of biopsied motor end-plates, and biochemical, immunocytochemical, and ultrastructural analyses are required to determine with certainty the cause of the disease in patients who do not have serologic evidence of autoimmunity to AChR. Assays for serum antibodies to AChR aid in the identification of patients with autoimmune myasthenia gravis and are useful in monitoring the response to immunosuppressive treatments.
|Original language||English (US)|
|Number of pages||2|
|Journal||Mayo Clinic proceedings|
|State||Published - Dec 1 1982|
ASJC Scopus subject areas